Clinical Trials Browser

Phase 4 × Lymphoma, Large B-Cell, Diffuse × fludarabine × Clear all

NCT05108805 2025-03-27

Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting

Phase 4 Completed

25 enrolled 17 charts

Lymphoma, Large B-Cell, Diffuse